Evidence map›Paper›PMID 42488743›Full record

ArticleJournal of contemporary brachytherapy2026

Iridium-192 high-dose-rate calibration discrepancies: A growing concern?

Paul Simpson, Emily Debrot, Neisha Hartfield, Diane Whitney, Claire Dempsey

Abstract read
In one paragraph

Article in Journal of contemporary brachytherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paul SimpsonRadiation Oncology, Calvary Mater Newcastle, NSW, Australia.
Emily DebrotRadiation Oncology, Calvary Mater Newcastle, NSW, Australia.
Neisha HartfieldRadiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, United Kingdom.
Diane WhitneyMedical Physics Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Claire DempseyRadiation Oncology, Calvary Mater Newcastle, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: An increasing discrepancy between the measured reference air kerma rate (RAKR) of high-dose-rate (HDR) iridium-192 ( Material and methods: A survey was distributed to physicists at brachytherapy clinics across Australia, New Zealand, the United Kingdom (UK), France, and Ireland, gathering details on HDR Results and Conclusions: One thousand one hundred fifty observations from 32 clinics were analyzed, with RAKR measurement histories ranging from 2 to 20 years (mean, 9 years). The manufacturer of all sources included in this analysis was Curium. A trend of increasing local measurement value compared with the manufacturer certificate value was observed for all series, with 20 or more observations. Sites with well chambers calibrated at NPL or UWADCL showed an increase in discrepancy between measured and source certificate RAKR, approximately 0.2% per year on average, from 2015 to present. There is an increasing discrepancy between locally measured

Indexed as

192IrcalibrationHDRQARAKRreference air kerma rate

Identifiers

PMID42488743
PMCPMC13389760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.